Trial intelligence / Profile preview

Ketoprofen lysinate lozenges for sore throat pain relief

2008-008265-36Phase 3Completed

Sponsor
Sanofi
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ketoprofen in pharyngitis (3 arms), sponsored by Sanofi. Primary endpoint: Total pain relief summed over 15 to 120 minutes (TOTPAR15–120) after first intake. Started Apr 2009; status: completed.

02

Drugs

ketoprofen
03

Conditions

pharyngitis

Beyond the preview

Go deeper on 2008-008265-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008265-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call